跳至主要内容
临床试验/NCT03846726
NCT03846726已完成不适用

Watch-and-wait Approach Versus Surgical Resection for Rectal Cancer Patients With Complete Clinical Response After Chemoradiotherapy: a Multi-center Cohort Study

Yuan-hong Gao1 个研究点 分布在 1 个国家目标入组 513 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
513
试验地点
1
主要终点
PFS

研究概览

简要总结

This was a propensity-score matched observational analysis, comparing the oncological outcome of surgical resection vs watch and wait apporach for rectal cancer patients with a cCR.

详细描述

Pathologically confirmed stage II/III rectal adenocarcinoma patients who received neoadjuvant chemoradiotherapy followed by a clinical complete response from the year 2010 to 2018 were included. Sequential subjects were identified from a prospective maintained database in the Sun Yat-sen University Cancer Center. Clinical experts on rectal cancer from other 5 regional medical centers in China were also invited to participate, and provided data of cCR patients. Standardized forms for data collection were sanded to researchers in each center. Patients received radical resection will constituted our surgery group. Those refused surgery constituted the observation group who went on with the watch and wait approach. A propensity-score matched observational analysis will be used to compare the oncological outcome of these two groups.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
16 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathologically confirmed stage II/III rectal adenocarcinoma patients who received neoadjuvant chemoradiotherapy followed by a clinical complete response

排除标准

  • history of a second primary malignancy.

结局指标

主要结局

PFS

时间窗: the time from the date of treatment started until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 60 months

progression-free survival

次要结局

  • OS(Overall survival was calculated from the date of first treatment until death from any cause or was censored at last follow-up, assessed up to 60 months)

研究者

发起方
Yuan-hong Gao
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Yuan-hong Gao

Principal Investigator, Clinical Professor

Sun Yat-sen University

研究点 (1)

Loading locations...

相似试验